Journal of Cardiology (@J_Cardiol) header
Journal of Cardiology (@J_Cardiol) profile picture

Journal of Cardiology #JCardiol is Official Journal of Japanese College of Cardiology〔日本心臓病学会〕and peer-reviewed cardiovascular journal. 2024 IF is 2.6 !!!

Japan
Joined April 2021
Photo by Journal of Cardiology (@J_Cardiol)Photo by Journal of Cardiology (@J_Cardiol)Photo by Journal of Cardiology (@J_Cardiol)Photo by Journal of Cardiology (@J_Cardiol)Photo by Journal of Cardiology (@J_Cardiol)Photo by Journal of Cardiology (@J_Cardiol)Photo by Journal of Cardiology (@J_Cardiol)Photo by Journal of Cardiology (@J_Cardiol)Photo by Journal of Cardiology (@J_Cardiol)Photo by Journal of Cardiology (@J_Cardiol)
J Cardiol’s 2026 Impact Factor is 3.5 Thanks to all of you! Our ranking among journals in the cardiovascular category has also been steadily rising: 92/231 in 2024 → 72/237 in 2025. And best of all, we have “no publication fees” in this day and age, so please do! #JCardiol
2
6
894
#JCardiol 88(5): 337-43, 2026 Topics: Contemporary TAVR... [Review] No-reflow phenomenon during percutaneous coronary intervention: Contemporary insights into mechanisms, prediction, and management Ozaki Y doi.org/10.1016/j.jjcc.2026.… by A.E. K
3
2
2
422
#JCardiol 88(5): 337-43, 2026 No-reflow phenomenon during percutaneous coronary... Highlights 3/3 •Prevention focuses on procedural adjustment and adjunctive pharmacotherapy. doi.org/10.1016/j.jjcc.2026.… by A.E. K
2
2
463
#JCardiol 88(5): 337-43, 2026 No-reflow phenomenon during percutaneous coronary... Highlights 2/3 •Intracoronary imaging helps identify high-risk plaques and prevention of no-reflow. doi.org/10.1016/j.jjcc.2026.… by A.E. K
2
2
453
#JCardiol 88(5): 337-43, 2026 No-reflow phenomenon during... Highlights 1/3 *No-reflow reflects microvascular impairment despite epicardial patency during PCI. •Mechanisms: distal embolization, reperfusion injury, microvascular dysfunction. doi.org/10.1016/j.jjcc.2026.… by A.E. K
2
2
295
#JCardiol 88(4): 335-6, 2026 [Letter to the Editors] Comment on “Beta-blocker therapy for acute myocardial infarction with preserved ejection fraction: A meta-analysis from randomized controlled trials” Wen S, Ouyang M doi.org/10.1016/j.jjcc.2026.… by A.E. K
2
2
371
#JCardiol 88(4): 334, 2026 [Letter to the Editors] Comment on “Biomarker-based pre-heart failure screening in a middle-aged rural population” Shabih A doi.org/10.1016/j.jjcc.2026.… by A.E. K
2
2
351
#JCardiol 88(4): 333, 2026 [Letter to the Editors] Early-phase heart rate after ECPR: Prognostic signal, physiologic mediator, or therapeutic target? Chen J, Ying G doi.org/10.1016/j.jjcc.2026.… by A.E. K
2
2
360
#JCardiol 88(4): 331-2, 2026 [Research Letters] Safety of same-day discharge after mitral transcatheter edge-to-edge repair Watanabe A et al doi.org/10.1016/j.jjcc.2026.… by A.E. K
3
2
3
431
#JCardiol 88(4): 331-2, 2026 Safety of same-day discharge after... Highlights 3/3 *Further studies are warranted to identify patients requiring prolonged monitoring. doi.org/10.1016/j.jjcc.2026.… by A.E. K
2
2
383
#JCardiol 88(4): 331-2, 2026 Safety of same-day discharge after... Highlights 2/3 *Same-day discharge may be a safe option for eligible patients undergoing M-TEER. doi.org/10.1016/j.jjcc.2026.… by A.E. K
2
3
309
#JCardiol 88(4): 331-2, 2026 Safety of same-day... Highlights 1/3 *We examined the safety of same-day discharge following M-TEER from national database. *The risks of death or readmissions were similar between same- and next-day discharge. doi.org/10.1016/j.jjcc.2026.… by A.E. K
2
2
324
#JCardiol 88(4): 329-30, 2026 [Research Letters] Utility of simplified PESI score for mid-term mortality risk stratification: Insights from the combined COMMAND-VTE registries Kageyama S et al doi.org/10.1016/j.jjcc.2026.… by A.E. K
3
3
3
520
#JCardiol 88(4): 329-30, 2026 Utility of simplified PESI score for mid-term mortality risk stratification... Highlights 3/3 *Patients with DVT alone had survival similar to PE with an sPESI score of 1. doi.org/10.1016/j.jjcc.2026.… by A.E. K
2
2
445
#JCardiol 88(4): 329-30, 2026 Utility of simplified PESI score for mid-term mortality risk stratification... Highlights 2/3 *Higher sPESI scores were associated with stepwise worse mid-term survival. doi.org/10.1016/j.jjcc.2026.… by A.E. K
2
2
354
#JCardiol 88(4): 329-30, 2026 Utility of simplified PESI... Highlights 1/3 *Nationwide registry of 8224 Japanese patients with acute venous thromboembolism *Simplified PESI (sPESI) was associated with 2.6-year all-cause mortality after PE. doi.org/10.1016/j.jjcc.2026.… by A.E. K
3
3
397
#JCardiol 88(4): 321-8, 2026 Association of 30-second chair stand test performance with exercise intolerance and hospitalization for symptomatic heart failure in type 2 diabetes and stage B heart failure Sugita Y et al doi.org/10.1016/j.jjcc.2026.… by A.E. K
3
6
908
#JCardiol 88(4): 297-320, 2026 Comparative outcomes of balloon-expandable and self-expanding valves in transcatheter aortic valve replacement: A systematic review and meta-analysis Hafez A et al doi.org/10.1016/j.jjcc.2026.… by A.E. K
3
2
2
530
#JCardiol 88(4): 297-320, 2026 Comparative outcomes of balloon-expandable and... Highlights 3/3 *Tailored valve selection is key. doi.org/10.1016/j.jjcc.2026.… by A.E. K
2
2
438
#JCardiol 88(4): 297-320, 2026 Comparative outcomes of balloon-expandable and... Highlights 2/3 *Self-expanding valves are associated with superior hemodynamics. *Safety outcomes (bleeding, vascular events, MI) comparable between valve types. doi.org/10.1016/j.jjcc.2026.… by A.E. K
2
2
425
#JCardiol 88(4): 297-320, 2026 Comparative outcomes... Highlights 1/3 *Balloon-expandable valves are associated with reduced early and 12-month mortality. *Balloon-expandable valves are associated with lower short-term need for new pacemaker. doi.org/10.1016/j.jjcc.2026.… by A.E. K
2
2
453